HomeURGN • NASDAQ
add
Urogen Pharma Ltd
Previous close
$12.70
Day range
$12.22 - $12.74
Year range
$10.60 - $20.70
Market cap
523.06M USD
Avg Volume
518.95K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
NDAQ
1.73%
0.94%
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 21.85M | 3.35% |
Operating expense | 45.46M | 33.39% |
Net income | -33.40M | -38.39% |
Net profit margin | -152.89 | -33.90% |
Earnings per share | -0.91 | 11.65% |
EBITDA | -25.77M | -69.83% |
Effective tax rate | -0.11% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 241.08M | 409.67% |
Total assets | 281.85M | 195.56% |
Total liabilities | 251.54M | 7.59% |
Total equity | 30.31M | — |
Shares outstanding | 42.11M | — |
Price to book | 17.16 | — |
Return on assets | -26.78% | — |
Return on capital | -68.64% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -33.40M | -38.39% |
Cash from operations | -23.75M | -17.14% |
Cash from investing | 12.00M | 222.53% |
Cash from financing | 100.28M | 70,029.37% |
Net change in cash | 88.54M | 639.49% |
Free cash flow | -11.88M | -9.51% |
About
Founded
2004
Headquarters
Website
Employees
203